Literature DB >> 23449344

Serpiginous-like choroiditis as a marker for tuberculosis in a non-endemic area.

Weh-Loong Gan1, Nicholas P Jones.   

Abstract

AIM: To describe the increasing incidence of multifocal outer retinal and inner choroidal inflammation as a marker for intraocular tuberculosis in the UK, a non-endemic area. PATIENTS AND METHODS: Retrospective case series.
RESULTS: 14 patients presented with serpiginous-like choroiditis over 10 years (seven within the last 2 years). Seven of 14 patients showed evidence of exposure to tuberculosis and received antituberculous treatment. 17 of 23 eyes showed stable or improved visual acuity. All with decreased acuity had direct macular involvement at presentation.
CONCLUSIONS: Multifocal outer retinal and inner choroidal inflammation is a marker for intraocular tuberculosis of increasing importance, even in a non-endemic area. Originally described as 'serpiginous-like choroiditis', the lesions are multifocal, irregular in shape, very numerous, widespread, often asymmetrical and often demonstrating both active and resolved lesions simultaneously. Active lesions show contiguous extension. We recommend that every patient with SLC should undergo testing for previous exposure to tuberculosis, and undergo antituberculous treatment if lesions are progressive and sight-threatening.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23449344     DOI: 10.1136/bjophthalmol-2012-302918

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area.

Authors:  N Krassas; J Wells; C Bell; M Woodhead; N Jones
Journal:  Eye (Lond)       Date:  2017-08-04       Impact factor: 3.775

2.  Splenic tuberculosis and multifocal serpiginoid choroiditis.

Authors:  Pradeep Kumar; Prateek Kakkar; Raghav Ravani; R Karthikeya; Atul Kumar
Journal:  Int Ophthalmol       Date:  2017-08-10       Impact factor: 2.031

3.  Endogenous Tuberculous Endophthalmitis and Panophthalmitis: A Systematic Review of Case Reports and Case Series.

Authors:  Fares Antaki; Simon Javidi; Samir Touma; Marie-Josée Aubin
Journal:  Clin Ophthalmol       Date:  2020-10-07

4.  Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.

Authors:  Rupesh Agrawal; Dinesh Visva Gunasekeran; Robert Grant; Aniruddha Agarwal; Onn Min Kon; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

5.  The spectrum of presumed tubercular uveitis in Tunisia, North Africa.

Authors:  Sana Khochtali; Salma Gargouri; Nesrine Abroug; Imen Ksiaa; Sonia Attia; Dorra Sellami; Jamel Feki; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2014-09-06       Impact factor: 2.031

Review 6.  [Serpiginous-like choroiditis and intraocular tuberculosis: report of 2 cases and literature review].

Authors:  Hakima Elouarradi; Samira Tachfouti; Lalla Ouafae Cherkaoui; Othmane Charhi; Uchama Daoudi; Saloua Khalil; Nouha Zerkaoui; Amal Alouane; Kamal Naciri; Rajae Daoudi
Journal:  Pan Afr Med J       Date:  2015-04-15

7.  Commentary: Serpiginous choroiditis-so near yet so far.

Authors:  Soumyava Basu
Journal:  Indian J Ophthalmol       Date:  2019-03       Impact factor: 1.848

8.  Serpiginoid choroiditis associated with presumed ocular tuberculosis.

Authors:  Te-An Wang; Kang-Jung Lo; De-Kuang Hwang; Shih-Jen Chen
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

Review 9.  Intraocular manifestations of mycobacterium tuberculosis: A review of the literature.

Authors:  Lauren A Dalvin; Wendy M Smith
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-02-17

Review 10.  Imaging in tuberculosis-associated uveitis.

Authors:  Reema Bansal; Soumyava Basu; Amod Gupta; Narsing Rao; Alessandro Invernizzi; Michal Kramer
Journal:  Indian J Ophthalmol       Date:  2017-04       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.